We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Stem Cells Predict Disease and Drug Toxicity

By Biotechdaily staff writers
Posted on 24 Dec 2007
Scientists have used human embryonic stem cells to predict the toxic effects of drugs and provide chemical clues to diagnosing disease. More...


All-purpose stem cells elicited and identified the chemical signals secreted by the stem cells when exposed to a drug known to cause autism. The research shows that stem cells have an immediate clinical application as they generate chemicals, biomarkers that can be used to predict the onset of disease, much like cholesterol or sugar in the blood can be used to forecast heart disease or diabetes.

In a new study, a team led by University of Wisconsin-Madison, (UW-Madison; Madison, WI, USA) biologist Prof. Gabriela Cezar measured the response of undifferentiated stem cells as well as precursor neural cells to the drug valproate, which is known to cause autism in the offspring of a small percentage of users. The drug is used to treat epilepsy, bipolar disease, and migraine headaches. "We [are] measuring active metabolites produced by the cells in response to an insult,” explained Dr. Cezar, a professor of animal science. "These are de facto signatures of what is happening in response to a drug or a disease state.”

Cells of all kinds use small-molecule chemicals as a way to communicate with other cells. Precise communication between cells is essential for normal development and the health of an organism. Such chemicals can be detected in blood, suggesting that it may be possible to devise simple tests that can provide disease diagnosis before birth or shortly after. The ability to tune in to the chemical chatter of stem cells may become a promising new window to helping scientists figure out, at the most fundamental level, what goes wrong to cause things such as birth defects and miscarriage.

In addition, the study shows how human embryonic stem cells and early precursor cells can be used to screen drugs for potentially harmful effects. Drug discovery and testing had been predicted to be one of the first technologies to emerge from embryonic stem cells.

The study was reported in the December 2007 journal Stem Cells and Development.


Related Links:
University of Wisconsin-Madison

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.